Antibiotic Apocalypse
Radiolab Podcast Recap
Published:
Duration: 1 hr 1 min
Guests: Aver Mitra, Stephanie Strathdee, Lance Price, Bruce Stewart Brown
Summary
This episode examines the escalating crisis of antibiotic resistance and its implications for medicine and public health. It highlights the urgent need for alternative treatments like phage therapy as traditional antibiotics lose effectiveness.
What Happened
Aver Mitra, an ER doctor, recounts how antibiotic resistance became apparent to him in 2006 when his father noticed that hand infection patients were not responding to antibiotics. Their research revealed that MRSA, a resistant bacteria, was infecting non-hospitalized individuals, signaling a broader community spread.
The discussion further explores how antibiotic resistance has grown since then, with MRSA infections initially being treatable with vancomycin. However, bacteria have developed resistance to even this last-line drug, leading to the use of older, more toxic antibiotics like colistin as a desperate measure.
Lance Price from the Antibiotic Resistance Action Center explains the role of agricultural antibiotic use in accelerating resistance. He highlights that 70% of antibiotics in the US are administered to animals, often leading to resistant strains that can transfer to humans.
Bruce Stewart Brown from Purdue Chicken shares the company's efforts to reduce antibiotic use by improving farm cleanliness and feed. By 2016, Purdue eliminated antibiotics from their feed, using them only to treat sick flocks, which helped curb the spread of resistance.
Stephanie Strathdee narrates how her husband, Tom, was treated with phage therapy after contracting a superbug resistant to all known antibiotics. This innovative approach uses viruses known as bacteriophages to target specific bacteria, offering a potential solution to antibiotic resistance.
Phage therapy is gaining traction globally, with clinical trials underway and dedicated centers like the University of California, San Diego's iPath leading the charge. The episode emphasizes the need for political will to advance this treatment quickly, akin to the rapid development of COVID-19 vaccines.
The episode concludes with the broader impact of antibiotic resistance, likening it to a slow-moving crisis that lacks urgency until it personally affects individuals. It underscores the historical context of humans being newcomers in the evolutionary battle against bacteria, with much yet to learn.
Key Insights
- Antibiotic resistance is accelerating, with MRSA becoming prevalent in the community, not just hospitals. This has led to a reliance on older, toxic antibiotics like colistin as newer drugs lose effectiveness.
- Agricultural practices significantly contribute to antibiotic resistance, with 70% of US antibiotics given to animals. This has led to resistant strains that can transfer to humans, exacerbating public health challenges.
- Phage therapy offers a promising alternative to traditional antibiotics, using viruses to target bacteria. It has shown success in treating infections resistant to all known antibiotics, as demonstrated by Tom's recovery.
- The development of new antibiotics has stalled since 1980 due to economic challenges, highlighting the need for innovative solutions like phage therapy and political support to address the antibiotic resistance crisis.